ACW ACW CEO presents at Bell Potter Healthcare Conference 2023 15/11/23 download Created with Sketch. 3.15MB Share ACW Application for quotation of securities - ACW 08/11/23 download Created with Sketch. 26.71KB Share ACW Actinogen appoints William Souter as new CFO 08/11/23 download Created with Sketch. 239.79KB Share ACW Amendment to Actinogen 2023 AGM resolutions 6 to 10 27/10/23 download Created with Sketch. 212.49KB Share ACW ACW CMO presents academic poster at CTAD 2023 conference 25/10/23 download Created with Sketch. 592.86KB Share ACW ACW CEO presentation for meetings at BIO Investor Forum USA 18/10/23 download Created with Sketch. 3.33MB Share ACW Actinogen September quarterly activity report & Appendix 4C 16/10/23 PRICE SENSITIVE download Created with Sketch. 511.35KB Share ACW Annual Report to Shareholders 13/10/23 download Created with Sketch. 4.19MB Share ACW Letter to Shareholders, Notice of AGM & Proxy Form 13/10/23 download Created with Sketch. 714.25KB Share ACW Notification of cessation of securities - ACW 11/10/23 download Created with Sketch. 21.52KB Share ACW ACW CEO presents to Dementia Trials Australia conference 06/10/23 download Created with Sketch. 1.69MB Share ACW ACW presents to the Asian Society Against Dementia congress 29/09/23 download Created with Sketch. 1.54MB Share ACW Change in substantial holding 27/09/23 download Created with Sketch. 166.64KB Share ACW Notification of buy-back - ACW 27/09/23 download Created with Sketch. 21.78KB Share ACW Date of AGM and Closing Date for Director Nominations 27/09/23 download Created with Sketch. 174.05KB Share ACW Actinogen enhances XanaMIA Phase 2b Alzheimers trial 26/09/23 PRICE SENSITIVE download Created with Sketch. 219.7KB Share ACW Change in substantial holding 20/09/23 download Created with Sketch. 166.67KB Share ACW Notification regarding unquoted securities - ACW 15/09/23 download Created with Sketch. 27.49KB Share ACW Application for quotation of securities - ACW 15/09/23 download Created with Sketch. 24.81KB Share ACW Appendix 3Y-Mr Malcolm McComas 12/09/23 download Created with Sketch. 195.82KB Share ACW Appendix 3Y-Dr George Morstyn 12/09/23 download Created with Sketch. 195.15KB Share ACW Appendix 3Y-Dr Steven Gourlay 12/09/23 download Created with Sketch. 194.14KB Share ACW Appendix 3Y-Dr Geoffrey Brooke 12/09/23 download Created with Sketch. 241.05KB Share ACW Notification regarding unquoted securities - ACW 11/09/23 download Created with Sketch. 23.88KB Share ACW Application for quotation of securities - ACW 11/09/23 download Created with Sketch. 24.91KB Share ACW Actinogen closes successful $10 million rights issue offer 07/09/23 PRICE SENSITIVE download Created with Sketch. 218.02KB Share ACW Prof Paul Maruff & Dr Dana Hilt webinar & slide deck 31/08/23 download Created with Sketch. 1.37MB Share ACW Actinogen FY2023 results, following the science 30/08/23 PRICE SENSITIVE download Created with Sketch. 269.85KB Share ACW Appendix 4G 30/08/23 download Created with Sketch. 286.39KB Share ACW Corporate Governance Statement 30/08/23 download Created with Sketch. 372.33KB Share ACW ACW Appendix 4E and 2023 Annual Report 30/08/23 PRICE SENSITIVE download Created with Sketch. 4.11MB Share ACW ACW secures further $0.5m rights issue shortfall commitment 30/08/23 PRICE SENSITIVE download Created with Sketch. 224.98KB Share ACW ACW appoints company for rights issue shareholder contact 30/08/23 download Created with Sketch. 269.47KB Share ACW Prof Paul Maruff on neuroscience drug development & Xanamem 29/08/23 download Created with Sketch. 217.16KB Share ACW Letter to Ineligible Shareholders 17/08/23 download Created with Sketch. 213.3KB Share ACW Letter to Eligible Shareholders - Rights Issue Opens 17/08/23 download Created with Sketch. 270.52KB Share ACW ACW secures shortfall commitments of $4.56m for rights issue 15/08/23 PRICE SENSITIVE download Created with Sketch. 222.88KB Share ACW Entitlement Offer Prospectus 08/08/23 PRICE SENSITIVE download Created with Sketch. 1.26MB Share ACW Proposed issue of securities - ACW 02/08/23 download Created with Sketch. 33.77KB Share ACW Actinogen announces $10 million rights offer 02/08/23 PRICE SENSITIVE download Created with Sketch. 259.74KB Share ACW Quarterly Activity Report & Appendix 4C 31/07/23 PRICE SENSITIVE download Created with Sketch. 330.43KB Share ACW Trading Halt 31/07/23 PRICE SENSITIVE download Created with Sketch. 642.62KB Share ACW ACW CEO presents at Bioshares Biotech Summit 25/07/23 download Created with Sketch. 2.7MB Share ACW Actinogen CMO presents academic poster to AAIC Conference 17/07/23 download Created with Sketch. 622.82KB Share ACW ACW CEO presentation on emerging oral Alzheimers therapies 21/06/23 download Created with Sketch. 1.49MB Share ACW ACW CEO & CMO present at BIO International Convention 05/06/23 download Created with Sketch. 1.52MB Share ACW ACW AD trial amendment and Clinical Science Forum slides 24/05/23 PRICE SENSITIVE download Created with Sketch. 1.69MB Share ACW Quarterly Activity Report & Appendix 4C 24/04/23 PRICE SENSITIVE download Created with Sketch. 325.71KB Share ACW Actinogen CMO presents at ADPD 2023 conference 31/03/23 download Created with Sketch. 1.38MB Share ACW Application for quotation of securities - ACW 20/03/23 download Created with Sketch. 26.61KB Share ACW Appendix 3X - Dr Nicki Vasquez 01/03/23 download Created with Sketch. 149.99KB Share ACW ACW appoints Dr Nicki Vasquez as a Non-Executive Director 01/03/23 download Created with Sketch. 244KB Share ACW Actinogen CEO presents to Spark Plus Biotech conference 24/02/23 download Created with Sketch. 1.71MB Share ACW Appendix 4D & Half-Year Financial Statements 22/02/23 PRICE SENSITIVE download Created with Sketch. 1.33MB Share ACW Actinogen appoints Dr Dana Hilt as Chief Medical Officer 01/02/23 download Created with Sketch. 240.38KB Share ACW Quarterly Activity Report & Appendix 4C 30/01/23 PRICE SENSITIVE download Created with Sketch. 389.51KB Share ACW ACW CEO presentation Sachs Neuroscience and JPM week 09/01/23 download Created with Sketch. 1.54MB Share ACW Letter to Shareholders - CEO 2022 Review & Outlook 22/12/22 download Created with Sketch. 394.21KB Share ACW FDA agrees to six-month Phase 2b Alzheimers Disease Trial 22/12/22 PRICE SENSITIVE download Created with Sketch. 235.52KB Share ACW Cleansing Notice 09/12/22 download Created with Sketch. 205.68KB Share ACW Application for quotation of securities - ACW 09/12/22 download Created with Sketch. 24.71KB Share ACW First patient treated in XanaCIDD Phase 2 Depression Trial 08/12/22 PRICE SENSITIVE download Created with Sketch. 230.87KB Share ACW Actinogen poster presentation at CTAD conference 2022 05/12/22 download Created with Sketch. 516.21KB Share ACW Constitution 16/11/22 download Created with Sketch. 424.43KB Share ACW Results of AGM 16/11/22 download Created with Sketch. 234.15KB Share ACW Actinogen AGM Chair address & CEO presentation 16/11/22 download Created with Sketch. 2.42MB Share ACW Appendix 3Y - Dr George Morstyn 11/11/22 download Created with Sketch. 192.7KB Share ACW Cleansing Notice 11/11/22 download Created with Sketch. 204.85KB Share ACW Application for quotation of securities - ACW 11/11/22 download Created with Sketch. 24.76KB Share ACW ACW CEO presentation to Bell Potter Healthcare Conference 09/11/22 download Created with Sketch. 2.76MB Share ACW Appendix 3Y - Dr Steven Gourlay 04/11/22 download Created with Sketch. 190.59KB Share ACW Actinogen CEO presentation to Spark Plus Healthcare Day 03/11/22 download Created with Sketch. 2.31MB Share ACW Quarterly Activity Report & Appendix 4C 28/10/22 PRICE SENSITIVE download Created with Sketch. 489.86KB Share ACW Actinogen CEO presentation to ShareCafe investor webinar 21/10/22 download Created with Sketch. 2.04MB Share ACW R&D tax incentive rebate received 20/10/22 PRICE SENSITIVE download Created with Sketch. 204.95KB Share ACW Annual Report to Shareholders 14/10/22 download Created with Sketch. 7.5MB Share ACW Letter to Shareholders, Notice of AGM & Proxy Form 14/10/22 download Created with Sketch. 854.98KB Share ACW ACW clinical biomarker study webcast presentation 10/10/22 PRICE SENSITIVE download Created with Sketch. 2.4MB Share ACW ACW announces positive Alzheimers Disease clinical results 10/10/22 PRICE SENSITIVE download Created with Sketch. 300.23KB Share ACW Trading Halt 06/10/22 PRICE SENSITIVE download Created with Sketch. 272.6KB Share ACW Date of AGM and Closing Date for Director Nominations 28/09/22 download Created with Sketch. 204.74KB Share ACW Actinogen AD Biomarkers Context & History Presentation 13/09/22 download Created with Sketch. 2.94MB Share ACW Appendix 4G 25/08/22 download Created with Sketch. 285.67KB Share ACW Corporate Governance Statement 25/08/22 download Created with Sketch. 380.16KB Share ACW Actinogen FY22 Results - Accelerating Clinical Development 25/08/22 PRICE SENSITIVE download Created with Sketch. 254.15KB Share ACW ACW Appendix 4E and 2022 Annual Report 25/08/22 PRICE SENSITIVE download Created with Sketch. 4.92MB Share ACW Actinogen Spark Plus non deal roadshow investor presentation 11/08/22 download Created with Sketch. 1.9MB Share ACW Actinogen Clinical Trials Science Forum presentation slides 03/08/22 download Created with Sketch. 5.15MB Share ACW ACW CEO presentation to Spark Plus Aust Equities Day 28/07/22 download Created with Sketch. 3.3MB Share ACW Quarterly Activity Report & Appendix 4C 28/07/22 PRICE SENSITIVE download Created with Sketch. 348.85KB Share ACW ACW CEO to present at Spark Plus Aust Equities Day 25/07/22 download Created with Sketch. 218.79KB Share ACW Actinogen Clinical Trials Science Forum Save the Date 21/07/22 download Created with Sketch. 217.82KB Share ACW Application for quotation of securities - ACW 15/07/22 download Created with Sketch. 26.29KB Share ACW Actinogen Alzheimer Disease Biomarker Study Timing & Design 13/07/22 download Created with Sketch. 257.67KB Share ACW ACW Presentation for BIO International Convention meetings 14/06/22 download Created with Sketch. 4.01MB Share ACW ACW announces Phase 2 trial designs for AD & MDD 14/06/22 PRICE SENSITIVE download Created with Sketch. 556.64KB Share ACW Change in substantial holding 01/06/22 download Created with Sketch. 181.96KB Share ACW Application for quotation of securities - ACW 24/05/22 download Created with Sketch. 26.8KB Share ACW Appendix 3Y - Dr Geoff Brooke 24/05/22 download Created with Sketch. 192.25KB Share ACW Appendix 3Y - Dr Steven Gourlay 13/05/22 download Created with Sketch. 191.3KB Share
(20min delay)
